Intratumoral HER2 heterogeneity in breast cancer

Clin Adv Hematol Oncol. 2020 Sep;18(9):535-537.
No abstract available

Publication types

  • Interview

MeSH terms

  • Breast Neoplasms* / genetics
  • Breast Neoplasms* / metabolism
  • Breast Neoplasms* / pathology
  • Breast Neoplasms* / therapy
  • Female
  • Humans
  • Receptor, ErbB-2 / genetics*
  • Receptor, ErbB-2 / metabolism*

Substances

  • ERBB2 protein, human
  • Receptor, ErbB-2